U.S. markets close in 2 hours 27 minutes
  • S&P 500

    4,410.06
    +42.58 (+0.97%)
     
  • Dow 30

    35,061.51
    +238.16 (+0.68%)
     
  • Nasdaq

    14,824.54
    +139.95 (+0.95%)
     
  • Russell 2000

    2,200.35
    +0.87 (+0.04%)
     
  • Crude Oil

    71.94
    +0.03 (+0.04%)
     
  • Gold

    1,801.90
    -3.50 (-0.19%)
     
  • Silver

    25.22
    -0.17 (-0.65%)
     
  • EUR/USD

    1.1776
    +0.0003 (+0.0235%)
     
  • 10-Yr Bond

    1.2880
    +0.0230 (+1.82%)
     
  • Vix

    17.25
    -0.44 (-2.49%)
     
  • GBP/USD

    1.3763
    -0.0005 (-0.0344%)
     
  • USD/JPY

    110.5330
    +0.4180 (+0.3796%)
     
  • BTC-USD

    32,133.79
    -238.59 (-0.74%)
     
  • CMC Crypto 200

    775.91
    -17.82 (-2.25%)
     
  • FTSE 100

    7,027.58
    +59.28 (+0.85%)
     
  • Nikkei 225

    27,548.00
    +159.80 (+0.58%)
     

Sabra Health Care REIT, Inc. to Participate in Nareit’s REITworld 2020 Annual Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chairman and Chief Executive Officer, Harold Andrews, the company’s Chief Financial Officer, Talya Nevo-Hacohen, the company’s Chief Investment Officer, and Michael Costa, the company’s Executive Vice President of Finance, will attend Nareit’s REITworld 2020 Annual Conference on November 17-19, 2020.

Additionally, Mr. Matros, Mr. Andrews, Ms. Nevo-Hacohen and Mr. Costa will be holding a virtual presentation at the conference on November 17, 2020 at 8:30am Pacific.

About Sabra

Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201103005652/en/

Contacts

Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com